Back
Quest Diagnostics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
46
DGX
Quest Diagnostics
Last Price:
139.55
Seasonality Move:
8.91%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
43.99
Seasonality Move:
10.8%
Sell
46
Quest Diagnostics (DGX)
is a Sell
Is Quest Diagnostics a Buy, Sell or Hold?
- The current Quest Diagnostics [DGX] share price is $134.26. The Score for DGX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $44.24. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DGX Stock Price Chart
What is Quest Diagnostics's stock price today?
-
The Quest Diagnostics share price today is $134.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DGX is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $44.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
DGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.29 | Buy |
Relative Strength Index (14 RSI): | 58.05 | Buy |
Chaikin Money Flow: | -471454 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.15 - 134.05) | Buy |
Bollinger Bands (100): | (126.54 - 136.22) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.09 | Sell |
Relative Strength Index (14 RSI): | 43.92 | Sell |
Chaikin Money Flow: | 101540 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.49 - 48.87) | Sell |
Bollinger Bands (100): | (43.62 - 49.46) | Sell |
DGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.92 | Buy |
20-day SMA: | 131.3 | Buy |
50-day SMA: | 128.94 | Buy |
200-day SMA: | 131.2 | Buy |
8-day EMA: | 133.13 | Buy |
20-day EMA: | 131.43 | Buy |
50-day EMA: | 130.37 | Buy |
200-day EMA: | 131.9 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.87 | Buy |
20-day SMA: | 46.21 | Sell |
50-day SMA: | 47.79 | Sell |
200-day SMA: | 42.13 | Buy |
8-day EMA: | 44.35 | Sell |
20-day EMA: | 45.49 | Sell |
50-day EMA: | 46.38 | Sell |
200-day EMA: | 44.57 | Sell |
Quest Diagnostics Earnings Growth & DGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.19 per share, an increase this year of $0.06 per share, and an increase next year of $0.64 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $0.95 per share.
Quest Diagnostics Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |